The Blood Collection Market is expected to grow from US$4.454 billion in 2025 to US$5.759 billion in 2030, at a CAGR of 5.27%.
The rising prevalence of chronic diseases, demand for liquid biopsy, and growing number of surgeries are anticipated to drive the growth of the global blood collection market in the coming five years. According to American Stroke Association, a whopping 92.1 million people in the United States are diagnosed with some kind of cardiovascular illness and 2300 mortalities happen every day in the United States owing to cardiovascular diseases. Also, the growing demand for blood components is further expected to fuel the market growth during the forecast period. Also, the number of emergency and accidental cases has been increasing around the world. Such patients need blood as a part of their treatment. These factors are anticipated to have a positive impact on the market and are expected to drive market growth in the coming five years.
There is now increased awareness among people regarding the connection of certain vitamins in our body like vitamin D and our immunity, which increased people’s focus on maintaining their blood vitamin levels, which is further expected to increase in the number of people getting their blood tests when some ailment arises and hence is anticipated to supplement the growth of blood collection market during the forecast period.
The blood collection market has been classified based on product, end-users, application, and geography. By product, the market has been classified into blood collection tubes, needles and syringes, blood bags, and lancets. By end-users, the segmentation has been done into hospitals, blood banks, diagnostic laboratories, and others. Whereas by application, the market has been categorized into diagnostics and treatment. North America, South America, Europe, the Middle East, and Africa, and the Asia Pacific are the 5 key regions analyzed thoroughly over the forecast period.
Physical inactivity in today’s world, especially in urban regions, is leading to the prevalence of a wide range of chronic illnesses. According to an estimate by World Health Organization (WHO) done in 2005, chronic diseases contributed to around 61 percent of all deaths i.e. 35 million and 49 percent of the global burden of disease. Furthermore, it is estimated that by 2030, the share of mortalities caused by chronic diseases will increase to 70 percent while it will contribute to 56 percent of the global burden of disease. This is expected to have a positive impact on the market growth and is anticipated to supplement the rise in the blood collection market. The Center for Disease Control and Prevention states that nearly six in ten adults in the United States have a chronic disease while four in ten adults have two or more chronic diseases. This is leading to an increasing number of blood check-ups being conducted in the United States.
According to International Diabetes Federation, the number of people with diabetes is projected to grow from 460 million in 2019 to 700 million in 2045. The increase in chronic diseases is a major driver for the growth of the blood collection market and is anticipated to propel the market growth during the forecast period.
By end-users, the hospital's segment is anticipated to hold a healthy market share during the next five years, which is attributable to the fact that hospitals being the place for treatment, conduct most of the tests for the patients as the diagnostic is generally done in the hospital itself under the recommendation of the doctor consulted in the hospital.
Geographically, the North American region is expected to hold a significant market share due to the rising government initiatives for blood safety, and the increasing prevalence of lifestyle diseases in the region. Furthermore, the region has good healthcare facilities which increases the tendency for blood testing. The Asia Pacific region is anticipated to witness substantial growth during the forecast period due to the rise in disposable income making more people conduct their blood tests now.
Prominent/major key market players in the blood collection market include Becton, Dickinson, and Company, Cardinal Health, and Medtronic, among others. The players in the Blood collection market are implementing various growth strategies to gain a competitive advantage over their competitors in this market. Major market players in the market have been covered along with their relative competitive strategies and the report also mentions recent deals and investments of different market players over the last few years. The company profiles section details the business overview, financial performance (public companies) for the past few years, key products and services being offered along with the recent deals and investments of these important players in the blood collection market.
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Report Metric | Details |
| Blood Collection Market Size in 2025 | US$4.454 billion |
| Blood Collection Market Size in 2030 | US$5.759 billion |
| Growth Rate | CAGR of 5.27% |
| Study Period | 2020 to 2030 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2030 |
| Forecast Unit (Value) | USD Billion |
| Segmentation |
|
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| List of Major Companies in the Blood Collection Market | |
| Customization Scope | Free report customization with purchase |
Segmentation